Accuray Incorporated (ARAY) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, Accuray Incorporated has achieved a revenue compound annual growth rate (CAGR) of 42.6%, while earnings have grown at -29.1% CAGR.
Historical revenue and profitability trends for Accuray Incorporated
The chart above illustrates Accuray Incorporated's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Accuray Incorporated's business.
How efficiently Accuray Incorporated converts revenue into profit
Profit margins reveal how much of each dollar of revenue Accuray Incorporated retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Accuray Incorporated to continue growing earnings in the coming year. The consensus analyst rating is 4.75 based on 4 analysts.
Based on our comprehensive analysis, Accuray Incorporated (ARAY) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Accuray Incorporated's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Accuray Incorporated stacks up against similar companies
Explore growth analysis for top stocks
Related: ARAY Valuation, ARAY Dividend, ARAY Financial Health
Compare: ARAY vs AAPL, ARAY vs MSFT, ARAY vs GOOGL